Bullish
AbbVie announced a $1.4 billion investment to construct a 185-acre pharmaceutical manufacturing campus in Durham, North Carolina. This state-of-the-ar...
Neutral
AbbVie (ABBV) is set to announce its earnings tomorrow before market hours. The market anticipates a 10.5% year-on-year revenue growth, an increase fr...
Bearish
AbbVie Inc. (ABBV) announced it received a Complete Response Letter (CRL) from the FDA regarding its Biologics License Application for trenibotulinumt...
Neutral
Sanctuary Advisors LLC increased its stake in AbbVie Inc. by 1.5% in the fourth quarter, purchasing an additional 6,911 shares, bringing its total hol...
Neutral
AbbVie (ABBV) has seen its share price soften recently, declining 10.55% year-to-date, despite strong longer-term returns. A popular valuation narrati...
Neutral
Diversified Management Inc. acquired a new position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) during the fourth quarter, according to the com...
Neutral
Patton Fund Management Inc. grew its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 740.6% in the 4th quarter, according to its most recent 13F ...
Neutral
Tyche Wealth Partners LLC increased its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 14.5% in the 4th quarter, according to the company in its...
Neutral
This article focuses on the capital expenditures per share for AbbVie, Inc. (BSESOF:4AB). It highlights financial data related to the company's CapEx ...